InvestorsHub Logo
Followers 39
Posts 6466
Boards Moderated 1
Alias Born 11/09/2019

Re: FIREMEDIC0001 post# 24681

Saturday, 07/30/2022 4:22:18 PM

Saturday, July 30, 2022 4:22:18 PM

Post# of 25012
Well to be honest there's a lack of credibility warranted here. The only virtue, albeit bullish, was the buyback or subsequent note purchase, increasing the restricted and inside percentage. The communications on corporate developments and general communications in regards to shareholder value are beyond the pale. They do have tight share structures, and a legitimate candidate for a RM. Given the financials, their objective to acquire businesses to achieve a 100 million revenue, was and is a massive stretch of imaginations. To put it nicely. The RM continues to be the best play on untapping value imo.

Here's the rest of the press release. Pay attention to the M and A part.

"Nexteligent continues to execute its strategy for building a distinguished brand recognized for delivering value to employees, clients and investors," said Paul Cristiano, Nexteligent chief executive officer. "Within the last 60 days, we have announced our plan to close three acquisitions before year-end 2021 and that in 2022 we intend to close acquisitions with a collective revenue of $100,000,000."

Cristiano also noted that Nexteligent recently announced that it has retained a leading M&A advisory and investment firm to assist in its acquisition process as well as a PCAOB auditor and counsel organization to assist in its plans for up listing to the OTCQX and to concurrently address and rectify any vagaries in convertible notes and service contracts discovered through the audit process required for admission to the OTCQX.